Literature DB >> 7475759

Anabolic steroid abuse and renal-cell carcinoma.

A A Bryden, P J Rothwell, P H O'Reilly.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7475759     DOI: 10.1016/s0140-6736(95)91915-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Near-fatal spontaneous hepatic rupture associated with anabolic androgenic steroid use: a case report.

Authors:  J J Patil; B O'Donohoe; C F Loyden; D Shanahan
Journal:  Br J Sports Med       Date:  2007-01-15       Impact factor: 13.800

Review 2.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

Review 3.  Steroid use and long-term health risks in former athletes.

Authors:  Miia Pärssinen; Timo Seppälä
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 4.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 5.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

Review 6.  Urological complications of illicit drug use.

Authors:  Sean C Skeldon; S Larry Goldenberg
Journal:  Nat Rev Urol       Date:  2014-02-18       Impact factor: 14.432

Review 7.  Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).

Authors:  Theodore Krasanakis; Taxiarchis Konstantinos Nikolouzakis; Markos Sgantzos; Theodore Mariolis-Sapsakos; John Souglakos; Demetrios A Spandidos; Christina Tsitsimpikou; Aristidis Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2019-10-03       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.